DK1025100T3 - 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf - Google Patents
3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen herafInfo
- Publication number
- DK1025100T3 DK1025100T3 DK98951491T DK98951491T DK1025100T3 DK 1025100 T3 DK1025100 T3 DK 1025100T3 DK 98951491 T DK98951491 T DK 98951491T DK 98951491 T DK98951491 T DK 98951491T DK 1025100 T3 DK1025100 T3 DK 1025100T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- derivatives
- substituted
- substituted tetrahydropyridopyrimidinone
- tetrahydropyridopyrimidinone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Structure And Mechanism Of Cameras (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19747063A DE19747063A1 (de) | 1997-10-24 | 1997-10-24 | 3-substituierte Tetrahydropyridopyrimidinon-Derivate, ihre Herstellung und Verwendung |
PCT/EP1998/006305 WO1999021857A1 (de) | 1997-10-24 | 1998-10-05 | 3-substituierte tetrahydropyridopyrimidinon-derivate, ihre herstellung und verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1025100T3 true DK1025100T3 (da) | 2002-05-06 |
Family
ID=7846539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK98951491T DK1025100T3 (da) | 1997-10-24 | 1998-10-05 | 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf |
Country Status (27)
Country | Link |
---|---|
US (1) | US6414157B1 (xx) |
EP (1) | EP1025100B1 (xx) |
JP (1) | JP2001521035A (xx) |
KR (1) | KR20010015787A (xx) |
CN (1) | CN1277611A (xx) |
AR (1) | AR015466A1 (xx) |
AT (1) | ATE212346T1 (xx) |
AU (1) | AU748666B2 (xx) |
BG (1) | BG104291A (xx) |
BR (1) | BR9812970A (xx) |
CA (1) | CA2305258A1 (xx) |
CO (1) | CO4980862A1 (xx) |
DE (2) | DE19747063A1 (xx) |
DK (1) | DK1025100T3 (xx) |
ES (1) | ES2172222T3 (xx) |
HR (1) | HRP980554A2 (xx) |
HU (1) | HUP0004648A3 (xx) |
ID (1) | ID24633A (xx) |
NO (1) | NO20001934L (xx) |
NZ (1) | NZ503486A (xx) |
PL (1) | PL340034A1 (xx) |
PT (1) | PT1025100E (xx) |
SK (1) | SK3872000A3 (xx) |
TR (1) | TR200001102T2 (xx) |
TW (1) | TW432063B (xx) |
WO (1) | WO1999021857A1 (xx) |
ZA (1) | ZA989664B (xx) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19900544A1 (de) * | 1999-01-11 | 2000-07-13 | Basf Ag | Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie |
AU2003253186A1 (en) * | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors |
US20040127501A1 (en) * | 2002-09-24 | 2004-07-01 | Zhengming Chen | Therapeutic agents useful for treating pain |
EP1560488B1 (en) | 2002-11-05 | 2010-09-01 | Glaxo Group Limited | Antibacterial agents |
CL2004000409A1 (es) * | 2003-03-03 | 2005-01-07 | Vertex Pharma | Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu |
US7160888B2 (en) * | 2003-08-22 | 2007-01-09 | Warner Lambert Company Llc | [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia |
US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
DE102004020908A1 (de) * | 2004-04-28 | 2005-11-17 | Grünenthal GmbH | Substituierte 5,6,7,8,-Tetrahydro-pyrido[4,3-d]pyrimidin-2-yl- und 5,6,7,8,-Tetrahydro-chinazolin-2-yl-Verbindungen |
CA2603049A1 (en) * | 2005-04-01 | 2006-10-05 | Warner-Lambert Company Llc | Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia |
JP4324221B2 (ja) * | 2005-08-26 | 2009-09-02 | 株式会社医薬分子設計研究所 | Pparアゴニスト活性を有する誘導体 |
CN102952129B (zh) * | 2011-08-16 | 2015-09-23 | 上海师范大学 | 四氢吡啶并二氢嘧啶酮衍生物及其制备方法和应用 |
EP4232450A4 (en) | 2020-10-21 | 2024-09-04 | Aligos Therapeutics Inc | BICYCLIC COMPOUNDS |
US11957683B2 (en) | 2021-06-18 | 2024-04-16 | Aligos Therapeutics, Inc. | Bicyclic compounds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0827149A (ja) * | 1994-07-08 | 1996-01-30 | Meiji Seika Kaisha Ltd | ピリミジノン誘導体およびその塩 |
-
1997
- 1997-10-24 DE DE19747063A patent/DE19747063A1/de not_active Withdrawn
-
1998
- 1998-10-05 CA CA002305258A patent/CA2305258A1/en not_active Abandoned
- 1998-10-05 NZ NZ503486A patent/NZ503486A/en unknown
- 1998-10-05 AT AT98951491T patent/ATE212346T1/de not_active IP Right Cessation
- 1998-10-05 DE DE59802922T patent/DE59802922D1/de not_active Expired - Fee Related
- 1998-10-05 ID IDW20000762D patent/ID24633A/id unknown
- 1998-10-05 KR KR1020007004362A patent/KR20010015787A/ko not_active Application Discontinuation
- 1998-10-05 AU AU97484/98A patent/AU748666B2/en not_active Ceased
- 1998-10-05 HU HU0004648A patent/HUP0004648A3/hu unknown
- 1998-10-05 WO PCT/EP1998/006305 patent/WO1999021857A1/de not_active Application Discontinuation
- 1998-10-05 TR TR2000/01102T patent/TR200001102T2/xx unknown
- 1998-10-05 ES ES98951491T patent/ES2172222T3/es not_active Expired - Lifetime
- 1998-10-05 SK SK387-2000A patent/SK3872000A3/sk unknown
- 1998-10-05 DK DK98951491T patent/DK1025100T3/da active
- 1998-10-05 BR BR9812970-8A patent/BR9812970A/pt not_active IP Right Cessation
- 1998-10-05 JP JP2000517967A patent/JP2001521035A/ja active Pending
- 1998-10-05 CN CN98810525A patent/CN1277611A/zh active Pending
- 1998-10-05 PT PT98951491T patent/PT1025100E/pt unknown
- 1998-10-05 PL PL98340034A patent/PL340034A1/xx unknown
- 1998-10-05 EP EP98951491A patent/EP1025100B1/de not_active Expired - Lifetime
- 1998-10-20 TW TW087117332A patent/TW432063B/zh not_active IP Right Cessation
- 1998-10-21 HR HR19747063.7A patent/HRP980554A2/hr not_active Application Discontinuation
- 1998-10-22 CO CO98061508A patent/CO4980862A1/es unknown
- 1998-10-23 ZA ZA9809664A patent/ZA989664B/xx unknown
- 1998-10-23 AR ARP980105297A patent/AR015466A1/es not_active Application Discontinuation
-
2000
- 2000-04-03 BG BG104291A patent/BG104291A/xx unknown
- 2000-04-10 US US09/529,231 patent/US6414157B1/en not_active Expired - Lifetime
- 2000-04-13 NO NO20001934A patent/NO20001934L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US6414157B1 (en) | 2002-07-02 |
WO1999021857A1 (de) | 1999-05-06 |
SK3872000A3 (en) | 2000-09-12 |
HUP0004648A2 (hu) | 2001-05-28 |
PL340034A1 (en) | 2001-01-15 |
TR200001102T2 (tr) | 2000-08-21 |
BG104291A (en) | 2001-05-31 |
NO20001934D0 (no) | 2000-04-13 |
ES2172222T3 (es) | 2002-09-16 |
NO20001934L (no) | 2000-04-13 |
CA2305258A1 (en) | 1999-05-06 |
HUP0004648A3 (en) | 2001-11-28 |
CO4980862A1 (es) | 2000-11-27 |
HRP980554A2 (en) | 1999-08-31 |
CN1277611A (zh) | 2000-12-20 |
TW432063B (en) | 2001-05-01 |
AU9748498A (en) | 1999-05-17 |
PT1025100E (pt) | 2002-07-31 |
AR015466A1 (es) | 2001-05-02 |
NZ503486A (en) | 2001-04-27 |
KR20010015787A (ko) | 2001-02-26 |
BR9812970A (pt) | 2000-08-08 |
ID24633A (id) | 2000-07-27 |
JP2001521035A (ja) | 2001-11-06 |
ATE212346T1 (de) | 2002-02-15 |
EP1025100B1 (de) | 2002-01-23 |
AU748666B2 (en) | 2002-06-06 |
DE59802922D1 (de) | 2002-03-14 |
DE19747063A1 (de) | 1999-04-29 |
ZA989664B (en) | 2000-04-25 |
EP1025100A1 (de) | 2000-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20021379D0 (no) | Benzodiazepin-derivater, fremstilling og anvendelse derav | |
NO20012567D0 (no) | Azepinoindolderivater, fremstilling og anvendelse derav | |
DK0908456T3 (da) | Pyrazolderivater, fremstilling deraf og anvendelse deraf i lægemidler | |
NO20021449D0 (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav | |
IS5696A (is) | Mótefni gegn CD23, afleiður þeirra og meðferðarnotkun þeirra | |
DK1454907T3 (da) | Quninazolin og pyridopyrmidin-derivativer | |
IS2076B (is) | Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja | |
IS6385A (is) | Ný notkun og nýjar N-asabísýkló-amíð afleiður | |
DK1112251T3 (da) | Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater | |
NO954369L (no) | Oksazolidindionderivater, deres fremstilling og anvendelse | |
DK1019358T3 (da) | 3,3-diarylpropylaminer, deres anvendelse og fremstilling | |
CY2013003I2 (el) | Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων | |
EE04721B1 (et) | Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine | |
DK0832104T3 (da) | Dolastatinderivater, deres fremstilling og anvendelse | |
NO975977L (no) | Substituerte purinderivater, fremgangsmÕter for fremstilling og anvendelse derav | |
NO307092B1 (no) | Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding | |
TR199800117A3 (tr) | Isaksazol- ve krotonasitamid türevleri ve bunlarin kullanimi. | |
IS6420A (is) | Setnar Fenýl-píperazín afleiður, framleiðsla þeirra og notkun | |
NO20013237L (no) | 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater | |
NO985307L (no) | Distamycinderivater, fremgangsmÕte for deres fremstilling, og deres anvende | |
DK1025100T3 (da) | 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf | |
NO992676D0 (no) | 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse | |
NO951811D0 (no) | Kinolin- og benzimidazolderivater, deres fremstilling og anvendelse | |
NO984921D0 (no) | Tienopyridinderivater og deres anvendelse | |
NO20003268L (no) | Hyperhydrert kitikolin, fremgangsmÕte og anvendelse |